Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus Nephropathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01331317
What this trial is testing

Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic Nephropathy

Who this might be right for
Cardiovascular DiseaseDiabetic Nephropathy
Peter Rossing 48
Post-approval studies (Phase 4)Study completedNCT02914691
What this trial is testing

Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesDiabetic Nephropathy
Peter Rossing 40
Testing effectiveness (Phase 2)Study completedNCT00464880
What this trial is testing

Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy

Who this might be right for
Diabetes Type 2
Novartis 24
Not applicableStudy completedNCT03844217
What this trial is testing

Copeptin After an Oral Stimulation With Macimorelin in Healthy Volunteers

Who this might be right for
Polyuria-polydipsia Syndrome
University Hospital, Basel, Switzerland 28
Not applicableLooking for participantsNCT04334707
What this trial is testing

Kidney Precision Medicine Project

Who this might be right for
Acute Kidney FailureAcute Kidney InsufficiencyAcute Renal Failure+12 more
Icahn School of Medicine at Mount Sinai 1,000
Not applicableStudy completedNCT02761434
What this trial is testing

The Effect of Vasopressin on Glucose Regulation

Who this might be right for
Insulin Resistance
University of Arkansas, Fayetteville 60
Post-approval studies (Phase 4)Not Yet RecruitingNCT07547878
What this trial is testing

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Baylor Research Institute 64
Not applicableStudy completedNCT04037436
What this trial is testing

Functional Exercise and Nutrition Education Program for Older Adults

Who this might be right for
Chronic DiseaseFrailDiabetes Mellitus+9 more
University of Waterloo 44
Post-approval studies (Phase 4)Study completedNCT00363987
What this trial is testing

Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN)

Who this might be right for
Diabetic Nephropathy
Fresenius Kabi 179
Early research (Phase 1)Looking for participantsNCT04789148
What this trial is testing

Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency

Who this might be right for
Vasopressin Deficiency
Elizabeth Austen Lawson 40
Not applicableNot Yet RecruitingNCT07352436
What this trial is testing

Gut Microbiota and Serum Metabolites as Predictors of Glycemic Variability and Outcomes in Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Eighth Affiliated Hospital, Sun Yat-sen University 270
Not applicableStudy completedNCT02864914
What this trial is testing

Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 Inhibitors

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 333,580
Not applicableStudy completedNCT04761016
What this trial is testing

The Integrated Population (I-POP) Health Trial

Who this might be right for
DiabetesHypertensionChronic Kidney Diseases+2 more
Baylor Research Institute 202
Testing effectiveness (Phase 2)Study completedNCT01371747
What this trial is testing

Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)

Who this might be right for
Chronic Kidney DiseaseHypertensionHyperkalemia
Relypsa, Inc. 324
Early research (Phase 1)Study completedNCT01555008
What this trial is testing

Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment

Who this might be right for
Type 2 Diabetes MellitusRenal Impairment
Lexicon Pharmaceuticals 31
Post-approval studies (Phase 4)Study completedNCT02628106
What this trial is testing

Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
West China Hospital 21
Testing effectiveness (Phase 2)Study completedNCT00811889
What this trial is testing

Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseType 2 DiabetesDiabetic Nephropathy
Biogen 227
Testing effectiveness (Phase 2)Study completedNCT00320021
What this trial is testing

Effect of Pyridorin in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
BioStratum 80
Not applicableUnknownNCT02844153
What this trial is testing

Metformin Use in Chronic Kidney Disease: The CKD-Met Study

Who this might be right for
Type 2 DiabetesChronic Kidney Disease
Hospices Civils de Lyon 1,000
Not applicableStudy completedNCT01323075
What this trial is testing

Pharmacodynamic Comparison of Truncal Blocks in Patients With or Without Metabolic Disease (Kidney Failure, Diabetes)

Who this might be right for
Renal InsufficiencyDiabetes
Centre Hospitalier Universitaire de Nīmes 120
Next Page